Association of THC Content and Price in Herbal Cannabis Products by Dispensaries in California
| Autor: | E. Alfonso Romero, Katharine Cunnane, Marybeth Dobbins |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
biology
Traditional medicine business.industry organic chemicals biology.organism_classification Anesthesiology and Pain Medicine Neurology mental disorders Medical cannabis medicine Potency Medicinal Cannabis Neurology (clinical) Cannabis Tetrahydrocannabinol business health care economics and organizations medicine.drug |
| Zdroj: | The Journal of Pain. 22:587 |
| ISSN: | 1526-5900 |
| Popis: | Eighty percent of medicinal cannabis users are pain patients. Tetrahydrocannabinol (THC), a main component of cannabis, reduces neuropathic pain at low potency ( 15% THC) dominate the legal U.S. cannabis market, medical and recreational. Even though demand could be a reason for this, financial gain could also play a role. We hypothesize that there is an association between THC content and price. We tested this hypothesis in CA since this was the first state to legalize medical cannabis in 1996. We randomly selected dispensaries across California, screened for a web presence, and noted product menu, THC content for herbal products, CBD content, price, type of product (flower or preroll), and chemovar (Sativa, Indica or Hybrid). We observed that more potent products (>15% THC) were more prevalent and more expensive than low potency ( |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|